Life Sciences
Data on life sciences discussed by researchers at University Hospital
Published in Medical Verdicts and Law Weekly, March 18th, 2010
Investigators publish new data in the report 'Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.' According to recent research from Zurich, Switzerland, "To assess the efficacy and safety of terguride, a partial dopamine agonist, in patients with fibromyalgia syndrome (FMS). In a 12-week, multicenter, double-blind, placebo-controlled, parallel-group study, 99 patients were randomized at a ratio of 2 to 1 to receive terguride or placebo."
"Over 21 days, the dosage was titrated to a maximum daily dose of 3 mg of terguride or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- AARP Idaho
Idaho Bill Puts Grandparents First for Foster Care of Grandchildren - Abt Associates
Dr. Allyson Ross Davies, Healthcare Quality Expert, to Lead Abt Associates Domestic Health Policy Practice - Accenture
Wave of U.S. Physicians Planning to Adopt Electronic Medical Records, Accenture Report Finds - Aetna
Aetna Introduces Paperless Contracting for Medical Professionals - Amazon Watch
Indigenous Achuar From the Peruvian Amazon Face Off Against Occidental Petroleum Over Destruction of Pristine Rainforest, as Reported by Amazon Watch - American Academy of Dermatology
American Academy of Dermatology Association Disappointed in Failure of Congress to Protect Access to Specialty Care for Medicare Patients - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
